Switch theme
Sign up to access all valuation multiples
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.
2011
23
LTM Revenue $23.1M
LTM EBITDA $13.3M
$61.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Saniona has a last 12-month revenue of $23.1M and a last 12-month EBITDA of $13.3M.
In the most recent fiscal year, Saniona achieved revenue of $33.2M and an EBITDA of $25.3M.
Saniona expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Saniona valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.7M | $33.2M | XXX | XXX | XXX |
| Gross Profit | $1.1M | $1.2M | XXX | XXX | XXX |
| Gross Margin | 64% | 4% | XXX | XXX | XXX |
| EBITDA | -$8.1M | $25.3M | XXX | XXX | XXX |
| EBITDA Margin | -487% | 76% | XXX | XXX | XXX |
| Net Profit | -$24.4M | -$9.5M | XXX | XXX | XXX |
| Net Margin | -1457% | -29% | XXX | XXX | XXX |
| Net Debt | n/a | $3.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Saniona's stock price is SEK 7 (or $1).
Saniona has current market cap of SEK 908M (or $90.1M), and EV of SEK 615M (or $61.1M).
See Saniona trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $61.1M | $90.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Saniona has market cap of $90.1M and EV of $61.1M.
Saniona's trades at 2.6x LTM EV/Revenue multiple, and 4.6x LTM EBITDA.
Analysts estimate Saniona's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Saniona and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $61.1M | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 2.4x | XXX | XXX | XXX |
| P/E | 4.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 2.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSaniona's NTM/LTM revenue growth is -43%
Saniona's revenue per employee for the last fiscal year averaged $1.4M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Saniona's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Saniona's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Saniona and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 1887% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 76% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -411% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 33% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 27% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Saniona acquired XXX companies to date.
Last acquisition by Saniona was XXXXXXXX, XXXXX XXXXX XXXXXX . Saniona acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Saniona founded? | Saniona was founded in 2011. |
| Where is Saniona headquartered? | Saniona is headquartered in Sweden. |
| How many employees does Saniona have? | As of today, Saniona has 23 employees. |
| Who is the CEO of Saniona? | Saniona's CEO is Mr. Thomas Feldthus. |
| Is Saniona publicy listed? | Yes, Saniona is a public company listed on STO. |
| What is the stock symbol of Saniona? | Saniona trades under SANION ticker. |
| When did Saniona go public? | Saniona went public in 2014. |
| Who are competitors of Saniona? | Similar companies to Saniona include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Saniona? | Saniona's current market cap is $90.1M |
| What is the current revenue of Saniona? | Saniona's last 12-month revenue is $23.1M. |
| What is the current EBITDA of Saniona? | Saniona's last 12-month EBITDA is $13.3M. |
| What is the current EV/Revenue multiple of Saniona? | Current revenue multiple of Saniona is 2.6x. |
| What is the current EV/EBITDA multiple of Saniona? | Current EBITDA multiple of Saniona is 4.6x. |
| What is the current revenue growth of Saniona? | Saniona revenue growth between 2023 and 2024 was 1887%. |
| Is Saniona profitable? | Yes, Saniona is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
